Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
JBMR Plus|December 16, 2024
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Clinical Genitourinary Cancer|May 30, 2025
Radical Prostatectomy Versus Radiation Therapy for Locally Advanced and Clinically Nodal Positive Prostate CancerMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
The Prostate|September 13, 2021
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplantMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
European Urology Focus|May 2, 2021
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation TherapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Frontiers in Surgery|December 31, 2020
Is Standardization Transferable? Initial Experience of Urethral Surgery at the University Hospital FrankfurtMike Wenzel, Marieke J Krimphove, Benedikt Lauer, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate CancerClara Humke, Benedikt Hoeh, Felix Preisser, et al.
BMC Bioinformatics|January 3, 2023
Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathologyYauheniya Zhdanovich, Jörg Ackermann, Peter J Wild, et al.
EJNMMI Research|July 3, 2021
Hematologic safety of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancerDaniel Groener, Cam Tu Nguyen, Justus Baumgarten, et al.
Cancer Causes & Control : CCC|March 22, 2021
Incidence rates and contemporary trends in primary urethral cancerMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
JBMR Plus|December 16, 2024
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancerMike Wenzel, Benedikt Hoeh, Clara Humke, et al.
Clinical Genitourinary Cancer|May 30, 2025
Radical Prostatectomy Versus Radiation Therapy for Locally Advanced and Clinically Nodal Positive Prostate CancerMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
The Prostate|September 13, 2021
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplantMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
European Urology Focus|May 2, 2021
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation TherapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Frontiers in Surgery|December 31, 2020
Is Standardization Transferable? Initial Experience of Urethral Surgery at the University Hospital FrankfurtMike Wenzel, Marieke J Krimphove, Benedikt Lauer, et al.
The Prostate|July 27, 2021
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patientsMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate CancerClara Humke, Benedikt Hoeh, Felix Preisser, et al.
BMC Bioinformatics|January 3, 2023
Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathologyYauheniya Zhdanovich, Jörg Ackermann, Peter J Wild, et al.
EJNMMI Research|July 3, 2021
Hematologic safety of <sup>177</sup>Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancerDaniel Groener, Cam Tu Nguyen, Justus Baumgarten, et al.
Cancer Causes & Control : CCC|March 22, 2021
Incidence rates and contemporary trends in primary urethral cancerMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Pageof 23